NCT07226544 2025-11-10Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerCity of Hope Medical CenterPhase 2 Not yet recruiting31 enrolled
NCT07218692 2025-10-20RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyCity of Hope Medical CenterPhase 2 Not yet recruiting35 enrolled